Two years ago, he co-authored a Nature commentary calling for a moratorium on
clinical embryo editing.
Not exact matches
Ishii notes that if the
clinical trial begins as planned, it would be the latest in a series of firsts for China in the field of CRISPR gene
editing, including the first CRISPR -
edited human
embryos, and the first CRISPR -
edited monkeys.
The paper has split scientists, with consensus on the need for a moratorium on
clinical applications but disagreement about whether to support basic research on
editing genes in human sperm, eggs, or
embryos.
In addition, Congress has prohibited the U.S. Food and Drug Administration from even considering whether to green - light a human
clinical trial using genome -
edited embryos.
«Their data reinforces the wisdom of the calls for a moratorium on any
clinical practice of
embryo gene
editing, because current methods are too inefficient and unsafe,» he wrote in an email.
(2) Currently, there is no reason to prohibit in vitro germline genome
editing on human
embryos and gametes, with appropriate oversight and consent from donors, to facilitate research on the possible future
clinical applications of gene
editing.